Pr Jean-Yves Blay
- Specialty
- Oncologist, sarcoma expert
- Title
- Director General
- Hospital
- Centre Léon Bérard (Lyon)
- Latest articles
-
- SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma. (Apr 1, 2025)
- Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial. (Mar 25, 2025)
- Case Report: Metastatic succinate dehydrogenase-deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor. (Mar 10, 2025)
- Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study. (Mar 4, 2025)
- Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement - OSAMA Study). (Feb 6, 2025)